CDK5 interacts with MST2 and modulates the Hippo signalling pathway
MST2 (STK3) is a major upstream kinase in the Hippo signalling pathway, an evolutionary conserved pathway in regulation of organ size, self‐renewal and tissue homeostasis. Its downstream effectors are the transcriptional regulators YAP and TAZ. This pathway is regulated by a variety of factors, such...
Saved in:
| Main Authors: | Mehak Passi, Jan B. Stöckl, Thomas Fröhlich, Simone Moser, Angelika M. Vollmar, Stefan Zahler |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-04-01
|
| Series: | FEBS Open Bio |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/2211-5463.13962 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Hippo Pathway in Kidney Development
by: Caroline M. Lara, et al.
Published: (2025-01-01) -
Emerging role and function of Hippo-YAP/TAZ signaling pathway in musculoskeletal disorders
by: Juanjuan Han, et al.
Published: (2024-10-01) -
The components and regulation of the Hippo pathway and its relationships with the progression and treatment of Non-small cell lung cancer (NSCLC)
by: Yuheng Feng, et al.
Published: (2025-08-01) -
Exploring the Revolutionary Impact of YAP Pathways on Physical and Rehabilitation Medicine
by: Carmelo Pirri
Published: (2025-01-01) -
Regulation of Hippo-YAP1/TAZ pathway in metabolic dysfunction-associated steatotic liver disease
by: Wei Xuan, et al.
Published: (2025-01-01)